Circulating Matrix Metalloproteinases for Prediction of Aortic Dilatation in Children with Bicuspid Aortic Valve: A

Amalia Făgărășan1,2, Maria Oana Săsăran3, Liliana Gozar1,2

  • 1Department of Pediatrics III, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540142 Târgu Mureș, Romania.

Insights

Tissue inhibitor of metalloproteinase-1 (TIMP-1) levels were higher in children with bicuspid aortic valve (BAV) but no aortic dilatation. TIMP-1 inversely correlated with aortic size, suggesting a potential role in BAV-associated aortic disease progression.

Area of Science:

  • Cardiovascular Medicine
  • Biomarkers
  • Genetics

Background:

  • Bicuspid aortic valve (BAV) is a common congenital heart defect associated with aortic dilatation and aneurysm formation.
  • Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) play a crucial role in extracellular matrix remodeling, implicated in aortic wall degradation.
  • Identifying biomarkers for early detection of aortic dilatation progression in pediatric BAV patients is critical for timely intervention.

Purpose of the Study:

  • To investigate the role of MMP-1, MMP-2, MMP-9, and TIMP-1 in children with BAV and their association with aortic dilatation.
  • To determine if these MMPs and TIMP-1 can serve as predictors of aortic aneurysm formation in pediatric BAV patients.

Main Methods:

  • A cohort of 73 children with BAV was divided into two groups: controls (n=43) and those with aortic dilatation (n=30).
  • Cardiac ultrasound was performed to assess aortic dimensions.
  • Serum levels of MMP-1, MMP-2, MMP-9, and TIMP-1 were quantified using xMAP technology.

Main Results:

  • TIMP-1 levels were significantly higher in the BAV control group compared to the BAV with aortic dilatation group.
  • TIMP-1 showed an inverse correlation with aortic annulus absolute size and z-score, and ascending aorta z-score.
  • No significant correlation was found between other MMPs (MMP-1, MMP-2, MMP-9) and aortic dilatation, nor between aortic phenotype and dilatation presence.

Conclusions:

  • TIMP-1 may play a protective role in the early stages of BAV-associated aortic disease, as indicated by its higher levels and inverse correlation with aortic size in patients without dilatation.
  • Further longitudinal studies in pediatric populations are warranted to explore the predictive significance of MMPs and TIMP-1 screening for aortic aneurysm development in BAV individuals.
  • These findings suggest potential utility of TIMP-1 as a biomarker in monitoring BAV-associated aortic remodeling.